Debating the UK impact agenda

Author(s):  
Katherine E. Smith ◽  
Justyna Bandola-Gill ◽  
Nasar Meer ◽  
Ellen Stewart ◽  
Richard Watermeyer

This chapter builds on the debates presented in chapters 1 and 2, providing a more in-depth assessment of critiques of the research impact agenda. This includes concerns expressed in the Stern review and debates regarding the possibility of applying ‘metrics’ to impact. It then considers how the impact agenda has been defended and amended in the context of these critiques.

ESMO Open ◽  
2018 ◽  
Vol 3 (1) ◽  
pp. e000258 ◽  
Author(s):  
Elena Pallari ◽  
Anthony W Fox ◽  
Grant Lewison

BackgroundThis is an appraisal of the impact of cited research evidence underpinning the development of cancer clinical practice guidelines (CPGs) by the professional bodies of the European Society for Medical Oncology (ESMO), the National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN).MethodsA total of 101 CPGs were identified from ESMO, NICE and SIGN websites across 13 cancer sites. Their 9486 cited references were downloaded from the Web of Science Clarivate Group database, analysed on Excel (2016) using Visual Basic Application macros and imported onto SPSS (V.24.0) for statistical tests.ResultsESMO CPGs mostly cited research from Western Europe, while the NICE and SIGN ones from the UK, Canada, Australia and Scandinavian countries. The ESMO CPGs cited more recent and basic research (eg, drugs treatment), in comparison with NICE and SIGN CPGs where older and more clinical research (eg, surgery) papers were referenced. This chronological difference in the evidence base is also in line with that ESMO has a shorter gap between the publication of the research and its citation on the CPGs. It was demonstrated that ESMO CPGs report more chemotherapy research, while the NICE and SIGN CPGs report more surgery, with the results being statistically significant.ConclusionsWe showed that ESMO, NICE and SIGN differ in their evidence base of CPGs. Healthcare professionals should be aware of this heterogeneity in effective decision-making of tailored treatments to patients, irrespective of geographic location across Europe.


2020 ◽  
pp. 137-160
Author(s):  
Katherine E. Smith ◽  
Justyna Bandola-Gill ◽  
Nasar Meer ◽  
Ellen Stewart ◽  
Richard Watermeyer

This chapter focuses on academics working in university-based groups that have been charged with, and funded to achieve, knowledge translation and research impact. These are, we suggest, academics working at the vanguard of the impact agenda, who we might consider as experimental subjects from whom we can learn. This chapter includes a summary of the types of knowledge brokerage roles and organisations that have been created in the UK and the perceived and stated rationales for these new roles and organisations, and an analysis of interview data providing insights into the perspectives of academics working within two such groups.


Author(s):  
Katherine E. Smith ◽  
Justyna Bandola-Gill ◽  
Nasar Meer ◽  
Ellen Stewart ◽  
Richard Watermeyer

This chapter briefly explains what we mean by ‘the impact agenda’ and what the UK approach to research impact assessment involves. This chapter also makes the case for why an empirical investigation of the recent changes associated with research impact assessment is required and provides key definitions and an overview of the rest of the book.


BMJ Open ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. e025025
Author(s):  
George Garas ◽  
Isabella Cingolani ◽  
Vanash M Patel ◽  
Pietro Panzarasa ◽  
Ara Darzi ◽  
...  

ObjectiveTo evaluate the role of the European Union (EU) as a research collaborator in the UK’s success as a global leader in healthcare research and innovation and quantify the impact that Brexit may have.DesignNetwork and regression analysis of scientific collaboration, followed by simulation models based on alternative scenarios.SettingInternational real-world collaboration network among all countries involved in robotic surgical research and innovation.Participants772 organisations from industry and academia nested within 56 countries and connected through 2397 collaboration links.Main outcome measuresResearch impact measured through citations and innovation value measured through the innovation index.ResultsGlobally, the UK ranks third in robotic surgical innovation, and the EU constitutes its prime collaborator. Brokerage opportunities and collaborators’ geographical diversity are associated with a country’s research impact (c=211.320 and 244.527, respectively; p<0·01) and innovation (c=18.819 and 30.850, respectively; p<0·01). Replacing EU collaborators with US ones is the only strategy that could benefit the UK, but on the condition that US collaborators are chosen among the top-performing ones, which is likely to be very difficult and costly, at least in the short term.ConclusionsThis study suggests what has long been argued, namely that the UK-EU research partnership has been mutually beneficial and that its continuation represents the best possible outcome for both negotiating parties. However, the uncertainties raised by Brexit necessitate looking beyond the EU for potential research partners. In the short term, the UK’s best strategy might be to try and maintain its academic links with the EU. In the longer term, strategic relationships with research powerhouses, including the USA, China and India, are likely to be crucial for the UK to remain a global innovation leader.


2010 ◽  
Vol 24 (5) ◽  
pp. 393-397 ◽  
Author(s):  
André Luiz de Campos

The experience of the UK Research Councils in assessing the impacts of their research funding is discussed, including a report on the findings of research which reviewed the impact studies implemented by the Research Councils. The response of the Councils to the challenge of demonstrating the impacts of their funding and the main methodologies used are presented and the implications of both for the Research Councils and policy makers elsewhere are outlined.


Author(s):  
Katherine Smith ◽  
Justyna Bandola-Gill ◽  
Nasar Meer ◽  
Ellen Stewart ◽  
Richard Watermeyer

As international interest in promoting and assessing the impact of research grows, this book examines the ensuing controversies, consequences and challenges. It places a particular emphasis on learning from experiences in the UK, since this is the country at the forefront of a range of new approaches to incentivising, monitoring and rewarding research impact achievements. The book aims to understand the origins and rationale for these changes and to critically assess their consequences for academic practice. Combining a review of existing literature with a range of new qualitative data (from interviews, focus groups and documentary analysis), The Impact Agenda is unique in providing a comprehensive, cross-disciplinary empirical examination of the ways in which various forms of research impact assessment are shaping academic practices. Although the primary focus of the book is on the UK, the book also considers the different approaches that other countries with an interest in research impact are taking (notably Australia, Canada and the Netherlands). While noting the benefits that the increasing emphasis on outward facing work is bringing, the book draws attention to a wide range of challenges and controversies associated with research impact assessment and, in particular, with the UK’s chosen approach. It concludes by using the insights in the book to propose an alternative, more theoretically robust approach to incentivising and rewarding efforts to undertake and use academic research for societal benefit.


2020 ◽  
Vol 28 ◽  
Author(s):  
Katy Jordan

The need to demonstrate the impact of research has become an important issue in the Higher Education sector in the UK. This has been taken care of through the introduction of ‘impact case studies’ as part of the research excellence framework (REF). The aim of the study presented in this paper was to understand the role that educational technology (and related terms) played in the 2014 REF impact case studies, using the public online database of case studies as a data source. Searches for 11 educational technology-related terms yielded a sample of 125 unique case studies. Although this represents only 1.9% of the total case studies, educational technology is clearly playing a role. The cases comprised two major subgroups: those where educational technology was the focus of the research (mainly associated with cases in education and computer science), and those where educational technology was used as a route to achieving impact (mainly in health-related subjects). The findings have implications for the contributions that educational technology and educational technologists can make in enhancing and supporting this important issue within their institutions.


2020 ◽  
pp. 115-136
Author(s):  
Katherine E. Smith ◽  
Justyna Bandola-Gill ◽  
Nasar Meer ◽  
Ellen Stewart ◽  
Richard Watermeyer

This chapter uses six in-depth interviews with high profile academics in a range of countries that have an interest in the notion of research impact: Australia, Canada, the UK and the US. Three of our interviewees are what we term ‘public intellectuals’, while the other three, each of whom works at the intersection of research and policy, we term ‘academic interlocutors’. These perspectives allow us to consider how academics working within and beyond the UK, with some contrasting views about external engagement, view notions of ‘public intellectualism’, ‘relevance’ and ‘impact’.


Author(s):  
Laura North ◽  
Christopher Orton ◽  
John Gallacher ◽  
Ronan Lyons ◽  
David Ford ◽  
...  

IntroductionThe Dementias Platform UK (DPUK) Data Portal is a secure, accessible environment facilitating provision of rich data towards the largest Dementia, cognition and ageing community of cohort studies in the world. DPUK is also providing services for cohort studies and researchers to maximise the research potential of the programme’s community. Objectives and ApproachAs part of the engagement of DPUK cohorts with the Data Portal, cohorts will upload data onto the DPUK instance of UK Secure eResearch Platform infrastructure. The Data Portal allows access to a collaborative working space that allows cohorts to enrich their own data, perform their own analysis, and enhance the research potential of their data whilst making use of expertise at various DPUK sites, such as data linking, curation and multi-modal specialism. Cohort data divided into ontologies allows researchers to access data specific to their study needs and can be requested from multiple cohorts simultaneously. ResultsBy utilising the Data Portal researchers have access to cohort data that has been prepared for dementia epidemiology using the agreed ontologies, providing more rapid access to cohort data that otherwise may be large and complex. The knowledge and experience of DPUK staff and collaborators can also help to guide nascent cohorts and feasibility studies into producing research-ready datasets, enabling them to achieve greater impact with their data. A range of analytical tools are provided on the Data Portal making analysis of a cohort’s own data or multiple independent datasets more accessible. Alongside data curation, DPUK also facilitates data linkage to routine sources, beginning with a Wales-wide use case that will expand to the UK over the course of the project. Conclusion/ImplicationsData from international sources accessible using a central platform permits international collaboration, with ontologies allowing previously disparate data to be combined and analysed to build knowledge and research impact. DPUK projects create policy leading results and operational research standards, enhancing cohort impact and discovery of benefits for Dementia patients.


Sign in / Sign up

Export Citation Format

Share Document